Caszyme CEO, Monika Paule, is featured in The Medicine Maker!
The article “Starting a Business in CRISPR” follows Monika’s career, from a childhood filled with natural curiosity and surrounded by science, through her move into business and innovation, ultimately, to the founding of Caszyme.
This engaging conversation also offers a thoughtful perspective on the current state of the CRISPR field.
As Monika observes, the industry is shifting beyond the initial hype into “a more mature phase for CRISPR, where the industry is reevaluating how to move forward more thoughtfully.”
She reflects on both the promise and the complexity of gene editing. While challenges are inevitable, the technological foundation is strong and full of potential.
Monika emphasizes the need for consistent and efficient work: “We don’t always need to go bigger – we need to go smarter.”
Read the full conversation here.